BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 20662276)

  • 21. Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy.
    Tokumura A; Kume T; Taira S; Yasuda K; Kanzaki H
    Mol Hum Reprod; 2009 May; 15(5):301-10. PubMed ID: 19297419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.
    Block RC; Duff R; Lawrence P; Kakinami L; Brenna JT; Shearer GC; Meednu N; Mousa S; Friedman A; Harris WS; Larson M; Georas S
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):87-95. PubMed ID: 20106646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory-Based Clinical Research I am Aiming for].
    Yatomi Y
    Rinsho Byori; 2014 Nov; 62(11):1052-5. PubMed ID: 27509720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
    Khurana S; Tomar A; George SP; Wang Y; Siddiqui MR; Guo H; Tigyi G; Mathew S
    Exp Cell Res; 2008 Feb; 314(3):530-42. PubMed ID: 18054784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.
    Tanaka M; Okudaira S; Kishi Y; Ohkawa R; Iseki S; Ota M; Noji S; Yatomi Y; Aoki J; Arai H
    J Biol Chem; 2006 Sep; 281(35):25822-30. PubMed ID: 16829511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation and biological activities of the autotaxin-LPA axis.
    van Meeteren LA; Moolenaar WH
    Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
    Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
    Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
    Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophospholipase D and its role in LPA production.
    Xie Y; Meier KE
    Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
    Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
    Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis.
    Li S; Wang B; Xu Y; Zhang J
    Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
    Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white.
    Morishige J; Touchika K; Tanaka T; Satouchi K; Fukuzawa K; Tokumura A
    Biochim Biophys Acta; 2007 Apr; 1771(4):491-9. PubMed ID: 17321793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.
    North EJ; Osborne DA; Bridson PK; Baker DL; Parrill AL
    Bioorg Med Chem; 2009 May; 17(9):3433-42. PubMed ID: 19345587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.